Literature DB >> 18925491

The bone marrow, B cells, and JC virus.

Sidney A Houff, Joseph R Berger.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18925491     DOI： 10.1080/13550280802348222

Source DB:  PubMed          Journal:  J Neurovirol        ISSN： 1355-0284            Impact factor:   2.643


× No keyword cloud information.
  20 in total

Review 1.  A classification scheme for human polyomavirus JCV variants based on the nucleotide sequence of the noncoding regulatory region.

Authors:  P N Jensen; E O Major
Journal:  J Neurovirol       Date:  2001-08       Impact factor: 2.643

Review 2.  Transcriptional networks in developing and mature B cells.

Authors:  Patrick Matthias; Antonius G Rolink
Journal:  Nat Rev Immunol       Date:  2005-06       Impact factor: 53.106

3.  Sequence rearrangement in JC virus DNAs molecularly cloned from immunosuppressed renal transplant patients.

Authors:  Y Yogo; T Kitamura; C Sugimoto; K Hara; T Iida; F Taguchi; A Tajima; K Kawabe; Y Aso
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

4.  JC virus infection in cells from lymphoid tissue.

Authors:  M C Monaco; J Shin; E O Major
Journal:  Dev Biol Stand       Date:  1998

5.  Human polyomavirus JC promoter/enhancer rearrangement patterns from progressive multifocal leukoencephalopathy brain are unique derivatives of a single archetypal structure.

Authors:  G S Ault; G L Stoner
Journal:  J Gen Virol       Date:  1993-08       Impact factor: 3.891

6.  Detection of the archetypal regulatory region of JC virus from the tonsil tissue of patients with tonsillitis and tonsilar hypertrophy.

Authors:  Atsushi Kato; Tadaichi Kitamura; Tomokazu Takasaka; Takashi Tominaga; Akira Ishikawa; Huai-Ying Zheng; Yoshiaki Yogo
Journal:  J Neurovirol       Date:  2004-08       Impact factor: 2.643

7.  Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients.

Authors:  Raija L P Lindberg; Lutz Achtnichts; Francine Hoffmann; Jens Kuhle; Ludwig Kappos
Journal:  J Neuroimmunol       Date:  2008-02-21       Impact factor: 3.478

8.  Detection of JC virus DNA in peripheral lymphocytes from patients with and without progressive multifocal leukoencephalopathy.

Authors:  C Tornatore; J R Berger; S A Houff; B Curfman; K Meyers; D Winfield; E O Major
Journal:  Ann Neurol       Date:  1992-04       Impact factor: 10.422

9.  Detection of JC virus DNA in human tonsil tissue: evidence for site of initial viral infection.

Authors:  M C Monaco; P N Jensen; J Hou; L C Durham; E O Major
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

10.  Progressive multifocal leukoencephalopathy in HIV-1-infected children.

Authors:  J R Berger; G Scott; J Albrecht; A L Belman; C Tornatore; E O Major
Journal:  AIDS       Date:  1992-08       Impact factor: 4.177
View more
  17 in total

Review 1.  Progressive multifocal leukoencephalopathy and newer biological agents.

Authors:  Joseph R Berger
Journal:  Drug Saf       Date:  2010-11-01       Impact factor: 5.606

2.  Assessment of the risk of polyomavirus JC reactivation in patients with immune-mediated diseases during long-term treatment with infliximab.

Authors:  Simone Giannecchini; Valeria Clausi; Alessandra Vultaggio; Lisa Macera; Fabrizio Maggi; Francesco Martelli; Alberta Azzi; Enrico Maggi; Andrea Matucci
Journal:  J Neurovirol       Date:  2012-01-27       Impact factor: 2.643

3.  Monoclonal antibodies and progressive multifocal leukoencephalopathy.

Authors:  Joseph R Berger; Sidney A Houff; Eugene O Major
Journal:  MAbs       Date:  2009 Nov-Dec       Impact factor: 5.857

Review 4.  Sorting out the risks in progressive multifocal leukoencephalopathy.

Authors:  Leonard H Calabrese; Eamonn Molloy; Joseph Berger
Journal:  Nat Rev Rheumatol       Date:  2014-10-14       Impact factor: 20.543

Review 5.  Treatment-Related Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis: A Comprehensive Review of Current Evidence and Future Needs.

Authors:  Emanuele D'Amico; Aurora Zanghì; Carmela Leone; Hayrettin Tumani; Francesco Patti
Journal:  Drug Saf       Date:  2016-12       Impact factor: 5.606

Review 6.  Update on progressive multifocal leukoencephalopathy.

Authors:  Israel Steiner; Joseph R Berger
Journal:  Curr Neurol Neurosci Rep       Date:  2012-12       Impact factor: 5.081

Review 7.  Host-Immune Interactions in JC Virus Reactivation and Development of Progressive Multifocal Leukoencephalopathy (PML).

Authors:  Amir Khalili; Michael Craigie; Martina Donadoni; Ilker Kudret Sariyer
Journal:  J Neuroimmune Pharmacol       Date:  2019-08-27       Impact factor: 4.147

Review 8.  Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain.

Authors:  Michael W Ferenczy; Leslie J Marshall; Christian D S Nelson; Walter J Atwood; Avindra Nath; Kamel Khalili; Eugene O Major
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

Review 9.  Multiple roles for Puralpha in cellular and viral regulation.

Authors:  Martyn K White; Edward M Johnson; Kamel Khalili
Journal:  Cell Cycle       Date:  2009-02-10       Impact factor: 4.534

Review 10.  Immune surveillance and response to JC virus infection and PML.

Authors:  Sarah Beltrami; Jennifer Gordon
Journal:  J Neurovirol       Date:  2013-12-03       Impact factor: 2.643
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.